Xeljanz 10 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FXND8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,994
Award facts
- Contract value 100% obligated
- $21,994.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,994.48 to AmerisourceBergen Drug Corp for the supply of Xeljanz 10 mg tablets (60-count units) on November 24, 2025, with an ultimate completion date of November 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Xeljanz delivery represents a routine pharmaceutical supply transaction consistent with AmerisourceBergen's extensive track record fulfilling federal medical supply requirements through the DLA Medical Supply Chain, which includes medications for various therapeutic areas ranging from specialty treatments to pain management and antibiotics.
Quick answers
Who was awarded contract SPE2DR26FXND8?
SPE2DR26FXND8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FXND8 worth?
The government has obligated $21,994 on SPE2DR26FXND8.
Is contract SPE2DR26FXND8 an order under another contract?
Yes. SPE2DR26FXND8 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXND8 competed?
The extent of competition for SPE2DR26FXND8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award